Biotechnology

Science Exchange Partners with Lab Launch to Help its Startups Advance Scientific Innovations

January 15, 2018

Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D), teamed up today with Lab Launch, a nonprofit working to provide affordable and high-quality laboratories to biotech startups. This partnership with Science Exchange allows Lab Launch’s resident companies to easily supplement and complement their in-house resources with external research […]

Cour Pharmaceuticals Receives FDA Fast Track Designation for TIMP-GLIA – A Novel Treatment for Celiac Disease under Clinical Development

January 15, 2018

Cour Pharmaceuticals Receives FDA Fast Track Designation for TIMP-GLIA – A Novel Treatment for Celiac Disease under Clinical Development TIMP-GLIA is designed to enable patients to develop tolerance to gluten Phase 1 program studying potential of new treatment option for people living with Celiac Disease   CHICAGO, Wednesday, January 10, 2018 Cour Pharmaceuticals today announced […]

44% of Life Science Professionals Already Using or Experimenting with AI and Deep Learning, Finds Survey from The Pistoia Alliance

January 9, 2018

94% expect an increase in use of Machine Learning within two years, but access to quality data and technical expertise is a barrier to adoption The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is calling on the pharmaceutical and technology industries to support […]

PEAR Therapeutics Completes $50 Million Series B Financing

January 3, 2018

Temasek Joins Current Investors to Advance Prescription Digital Therapeutics Platform BOSTON, and SAN FRANCISCO, January 2, 2018– PEAR Therapeutics, the leader in prescription digital therapeutics, today announced that it has successfully closed a $50 million Series B financing led by Temasek. With this financing, Temasek joins new and existing investors including 5AM Ventures, Arboretum Ventures, […]

Takeda’s Off-The-Shelf Stem Cell Therapy Closes in on EU Approval

December 27, 2017

The EMA has recommended approval of the first ever off-the-shelf stem cell therapy, Takeda and Tigenix’s Alofisel (darvadstrocel).   The European Medicines Agency (EMA) adopted a positive opinion recommending marketing authorisation of the candidate – previously known as Cx601 – last week taking Takeda and Tigenix one-step closer to landing the first EU approval for […]

FEEDBACK